Barnett & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $778K | Buy |
+16,810
| New | +$778K | 0.61% | 46 |
|
2022
Q1 | – | Sell |
-1,715
| Closed | -$107K | – | 119 |
|
2021
Q4 | $107K | Sell |
1,715
-40
| -2% | -$2.5K | 0.07% | 113 |
|
2021
Q3 | $104K | Sell |
1,755
-104
| -6% | -$6.16K | 0.08% | 103 |
|
2021
Q2 | $124K | Sell |
1,859
-46
| -2% | -$3.07K | 0.08% | 109 |
|
2021
Q1 | $120K | Sell |
1,905
-300
| -14% | -$18.9K | 0.06% | 125 |
|
2020
Q4 | $136K | Hold |
2,205
| – | – | 0.09% | 111 |
|
2020
Q3 | $133K | Hold |
2,205
| – | – | 0.09% | 110 |
|
2020
Q2 | $130K | Sell |
2,205
-300
| -12% | -$17.7K | 0.11% | 102 |
|
2020
Q1 | $140K | Hold |
2,505
| – | – | 0.13% | 93 |
|
2019
Q4 | $161K | Buy |
+2,505
| New | +$161K | 0.1% | 110 |
|
2016
Q3 | – | Sell |
-459
| Closed | -$34K | – | 393 |
|
2016
Q2 | $34K | Hold |
459
| – | – | 0.02% | 221 |
|
2016
Q1 | $29K | Buy |
+459
| New | +$29K | 0.02% | 245 |
|